Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Men who have sex with men (MSM) news

Show

From To
AT LAST: Gay men and transgender people get vaccine to prevent genital warts and anal cancer – impressive pilot results in England

Gay men and transgender people in England now have limited access to the HPV vaccine. Early results from an ongoing pilot study are extremely encouraging.

Published
18 January 2017
From
HIV i-Base
New HIV prevention treatment can only work if perception improves

A De Montfort University Leicester (DMU) professor and his PhD student have urged the medical profession and media to change the way in which a new HIV prevention treatment is represented if they want it to work. He found that men who would benefit most from taking PrEP were being put off by its association with “high risk” people – as they did not want to place themselves in this category.

Published
18 January 2017
From
De Montfort University (press release)
ChemSex care plan

A new online, interactive resource to assist healthcare practitioners to guide ChemSex patients through a behaviour-change Care Plan, is now live. Designed for people who use chems who might be unable or unwilling to access support services, or for drugs workers/sexual health staff in areas where there are no ChemSex support services

Published
17 January 2017
From
David Stuart
HIV treatment might boost susceptibility to syphilis, say researchers

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Published
17 January 2017
From
Eurekalert Medicine & Health
HIV diagnoses falling steeply, early figures show: London clinics see hope in increased use of pre-exposure prophylaxis

Early figures from four London sexual health clinics reveal a steep decline in the rate of HIV diagnoses in 2016, raising the possibility that the virus could be managed out of existence in the UK. The fall might be explained by the increased use of medicines called pre-exposure prophylaxis, or PrEP. The medicines are provided by the clinics but are also for sale online, though they are not available on the NHS.

Published
13 January 2017
From
Financial Times
No decrease in HIV infections among gay men per CDC data; More PrEP coverage needed

Country-wide, it seems like PrEP’s impact is much smaller than it could be. Far fewer people are taking PrEP now than need to be for PrEP to significantly reduce the percentage of new infections that happen every year.

Published
09 January 2017
From
BETA blog
Dear Gay Men, An Open Letter

The same kind of fear that keeps us from coming out as gay keeps many of us from coming out as HIV-positive.

Published
09 January 2017
From
Advocate
STI Diagnoses Rise Among PrEP Users in a Northern California Health System

Among a large group of people accessing Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) from a Northern California health system, the quarterly rates of rectal gonorrhea and urethral chlamydia increased steadily and about doubled after one year.

Published
05 January 2017
From
POZ
Gay Rights Groups Brave Abuse, Violence to Fight HIV in Cameroon

Cameroon has the second highest HIV prevalence rate in West and Central Africa, after Nigeria, and men who have sex with men are hit the hardest, says the U.N. AIDS program (UNAIDS).

Published
29 December 2016
From
NBCNews.com
Listerine gargle every day helps slow spread of gonorrhoea, study finds

Daily rinsing and gargling with a commercial brand of mouthwash could help control the spread of gonorrhoea, a study has found.

Published
20 December 2016
From
The Guardian

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.